Table 1 Association of AR expression with ccRCC specimens’ characteristics analyzed by logistic regression

From: Androgen receptor increases hematogenous metastasis yet decreases lymphatic metastasis of renal cell carcinoma

Valuables ( n )

AR positive ( n , %)

B

SE

p -value

OR (95% CI)

Gender

 

−1.627

0.680

0.017*

0.197(0.052–0.745)

 Male (70)

42 (60)

    

 Female (19)

7 (36.8)

    

Fuhrman Grade a

   

0.003*

 

 1 (17)

14 (82.4)

    

 2 (42)

26 (61.9)

−1.789

0.884

0.043

0.167 (0.030–0.945)

 3 (23)

7 (30.4)

−3.615

1.080

0.001

0.027 (0.003–0.224)

 4 (7)

2 (28.8)

−4.559

1.428

0.001

0.010 (0.001–0.172)

pT stage b

   

0.123

 

 T1 (54)

31 (57.4)

    

 T2 (9)

4 (44.4)

−1.350

0.878

0.124

0.259 (0.046–1.449)

 T3 (23)

12 (52.2)

1.296

0.745

0.082

3.655 (0.848–15.754)

 T4 (3)

2 (62.7)

22.420

15921.320

0.999

5.459E9 (0.000)

Pulmonary metastasis

 

1.904

0.842

0.024*

6.711 (1.289–34.929)

 No (76)

39 (51.3)

    

 Yes (13)

10 (76.9)

    

Lymphatic metastasis

 

−21.410

15921.320

0.999

0.000 (0.000)

 No (80)

47 (58.8)

    

 Yes (9)

2 (22.2)

    

Constant

 

7.174

3980.330

0.999

1304.430

  1. ccRCC clear cell renal cell carcinoma, CI confidence interval, OR odds ratio (male, non-pulmonary, and lymphatic metastasis as reference), SE standard error
  2. *Statistically significant
  3. aGrade 1 as reference
  4. bT1 as reference